Biodexa Pharmaceuticals (BDRX)
3.29
-0.16 (-4.64%)
At close: Feb 28, 2025, 3:58 PM
3.24
-1.67%
After-hours: Feb 28, 2025, 04:56 PM EST
Biodexa Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 381K | 699K | 578K | 343K | 674K | 1.94M | 989K | 1.32M | 1.38M | 157K | 147K | n/a |
| Cost of Revenue | 4.07M | 5.11M | 4.65M | 6.07M | 7.84M | 9.36M | 8.33M | 7.73M | 70K | n/a | n/a | n/a |
| Gross Profit | -3.69M | -4.41M | -4.08M | -5.72M | -7.17M | -7.42M | -7.34M | -6.41M | 1.3M | 157K | 147K | n/a |
| Operating Income | -8.01M | -8.93M | -7M | -10.67M | -11.32M | -11.81M | -11.78M | -9.65M | -10.09M | -7.71M | -4.5M | -4.01M |
| Interest Income | 83K | 24K | 44K | 33K | 89K | 585K | 94K | 91K | 48K | 153K | 384K | 557K |
| Pretax Income | -7.49M | -8.49M | -6.11M | -23.47M | -10.92M | -12.4M | -12.97M | -8.39M | -11.23M | -9.84M | -4.88M | -4.57M |
| Net Income | -7.08M | -7.66M | -5.46M | -22.19M | -9.14M | -10.37M | -11.71M | -6.16M | -10.1M | -8.82M | -4.08M | -3.99M |
| Selling & General & Admin | 4.34M | 4.54M | 2.95M | 4.96M | 4.16M | 4.39M | 4.44M | 3.25M | 2.69M | 4.23M | 1.81M | 2.36M |
| Research & Development | 4.07M | 5.11M | 4.65M | 16.15M | 7.84M | 9.36M | 9.83M | 7.73M | 8.71M | 5.44M | 2.84M | 1.65M |
| Other Expenses | -4.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 4.33M | 4.05M | 1.99M | 17.71M | 3.67M | 4.39M | 5.54M | 2.07M | 12.59M | 9.84M | 4.65M | 4.01M |
| Interest Expense | 41K | 53K | 44K | 34K | 97K | 587K | 109K | n/a | n/a | 161K | 248K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | 6K | 323K | n/a | 170K | n/a | 605K | n/a | n/a | n/a |
| Cost & Expenses | 8.39M | 9.16M | 6.64M | 23.78M | 11.51M | 13.75M | 13.87M | 9.8M | 12.65M | 9.84M | 4.65M | 4.01M |
| Income Tax | -406K | 832K | 646K | 1.28M | 1.78M | 2.03M | 1.26M | 2.23M | 1.13M | 1.02M | 799K | 571K |
| Shares Outstanding (Basic) | 31.59K | 12.35K | 10.07K | 5.36K | 2.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Diluted) | 31.59K | 12.35K | 10.07K | 5.36K | 2.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Basic) | -224.13 | -619.72 | -542.31 | -4.14K | -3.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Diluted) | -224.13 | -619.72 | -542.31 | -4.14K | -3.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA | -7.16M | -7.39M | -5.66M | -22.22M | -9.54M | -10.7M | -10.61M | -5.3M | -10.49M | -9.36M | -4.25M | -3.81M |
| Depreciation & Amortization | 283K | 343K | 403K | 1.22M | 1.28M | 1.11M | 1.17M | 4.35M | 736K | 321K | 246K | 194K |